Trademark: 90481362
Word
T T-DETECT
Status Date
Monday, September 11, 2023
Filing Date
Friday, January 22, 2021
Published for Opposition
Tuesday, December 13, 2022
Abandoned Date
Monday, September 11, 2023
5 Medical assay kits comprised of diagnostic reagents for medical use; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer, autoimmune disease and infection; medical immunosequencing-based assay kits comprised of diagnostic reagents for medical use; medical immunosequencing-based assay kits comprised of medical grade reagents and sample plates for detecting cancer, autoimmune disease and infection
44 Medical services; consulting services in the field of medical diagnostic and prognostic testing; medical analysis services related to the treatment of persons; medical analysis services for diagnostic and prognostic testing and treatment purposes; providing medical diagnostic and prognostic testing services; providing medical immunosequencing-based testing for cancer, autoimmune disease and infection; consulting services in the field of medical immunosequencing-based testing.
42 Development of new technology for others in the field of biotechnology; DNA analysis services for scientific research purposes; genetic testing for scientific research purposes; genome amplification; genotyping services for research or analysis purposes; laboratory research in the field of immune sequencing; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of immune sequencing; providing laboratory research services in the field of gene expression, namely, cancer biology; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; scientific research in the field of genetics and genetic engineering; DNA screening for scientific research purposes; medical research; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; custom design and development of chemical reagents and biochemical assays; development of new technology for others in the field of immunotherapy; laboratory research in the field of immunotherapy, oncology, hematology, auto-immunedisorders, and infectious diseases; medical and scientific research in the field of immunotherapy; medical laboratory services; medical laboratory immunosequencing-based services for analysis of biological samples
The mark consists of a capitalized letter "T" in stylized form, underneath which is the word "T-Detect".
Sep 11, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Sep 11, 2023
Abandonment - No Use Statement Filed
Feb 7, 2023
Noa E-Mailed - Sou Required From Applicant
Dec 13, 2022
Official Gazette Publication Confirmation E-Mailed
Dec 13, 2022
Published For Opposition
Nov 23, 2022
Notification Of Notice Of Publication E-Mailed
Nov 7, 2022
Approved For Pub - Principal Register
Nov 3, 2022
Examiner's Amendment Entered
Nov 3, 2022
Notification Of Examiners Amendment E-Mailed
Nov 3, 2022
Examiners Amendment E-Mailed
Nov 3, 2022
Examiners Amendment -Written
Apr 11, 2022
Notification Of Non-Final Action E-Mailed
Apr 11, 2022
Non-Final Action E-Mailed
Apr 11, 2022
Non-Final Action Written
Apr 5, 2022
Previous Allowance Count Withdrawn
Mar 8, 2022
Withdrawn From Pub - Og Review Query
Feb 24, 2022
Approved For Pub - Principal Register
Feb 1, 2022
Teas/Email Correspondence Entered
Jan 31, 2022
Correspondence Received In Law Office
Jan 31, 2022
Teas Response To Office Action Received
Jul 30, 2021
Notification Of Non-Final Action E-Mailed
Jul 30, 2021
Non-Final Action E-Mailed
Jul 30, 2021
Non-Final Action Written
Jul 20, 2021
Assigned To Examiner
Apr 23, 2021
New Application Office Supplied Data Entered
Jan 26, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
